Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrovent for Exercise Induced Laryngeal Obstruction
NCT02755714Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Jun 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ipratropium bromide in Exercise-induced laryngeal obstruction (EILO), sponsored by Haukeland University Hospital. Started Jun 2016; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
Exercise-induced laryngeal obstruction (EILO)
Beyond the preview
Go deeper on NCT02755714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755714.